These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25842949)

  • 1. [Flow-cytofluorometric study of bactericidal granules in blood phagocytes of animals with various species sensitivity to experimental plague infection].
    Kravtsov AL
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (1):23-31. PubMed ID: 25842949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative investigation of PMN leucocyte antimicrobial potential in animals of different species susceptibility to the plague agent.
    Isin ZhM; Suleimenov BM
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(3):307-12. PubMed ID: 2824603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative cytofluorimetric analysis of the blood leukocytes in guinea pigs exposed to the phospholipase D and antigens of the causative agent of plague].
    Sinichkina NA; Kravtsov AL; Naumov AV; Kuz'michenko IA; Taranenko TM; Zadumina SIu
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (11-12):52-4. PubMed ID: 1301664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early systemic bacterial dissemination and a rapid innate immune response characterize genetic resistance to plague of SEG mice.
    Demeure CE; Blanchet C; Fitting C; Fayolle C; Khun H; Szatanik M; Milon G; Panthier JJ; Jaubert J; Montagutelli X; Huerre M; Cavaillon JM; Carniel E
    J Infect Dis; 2012 Jan; 205(1):134-43. PubMed ID: 22090450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inheritance of the lysozyme inhibitor Ivy was an important evolutionary step by Yersinia pestis to avoid the host innate immune response.
    Derbise A; Pierre F; Merchez M; Pradel E; Laouami S; Ricard I; Sirard JC; Fritz J; Lemaître N; Akinbi H; Boneca IG; Sebbane F
    J Infect Dis; 2013 May; 207(10):1535-43. PubMed ID: 23402825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The protective activity of the adhesion pili of Yersinia pestis].
    Vodop'ianov SO; Rybianets AA; Verkina LM; Romanova LV; Sorokina TB; Mishan'kin BN
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):26-9. PubMed ID: 8525726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague.
    Lemaître N; Sebbane F; Long D; Hinnebusch BJ
    Infect Immun; 2006 Sep; 74(9):5126-31. PubMed ID: 16926404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenesis in White Mice Infected with Yersinia pestis with Different Plasmid Composition.
    Balakhonov SV; Vityazeva SA; Dubrovina VI; Starovoitova TP; Mukhturgin GB; Ivanova TA; Korytov KM; Kolesnikov SI
    Bull Exp Biol Med; 2017 Feb; 162(4):470-473. PubMed ID: 28243913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of serotonin on immune competent cells of biomodels under the conditions of vaccination against plague and tularemia].
    Kliueva SN; Kravtsov AL; Shchukovskaia TN
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (1):32-8. PubMed ID: 25842950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yersinia pestis requires the 2-component regulatory system OmpR-EnvZ to resist innate immunity during the early and late stages of plague.
    Reboul A; Lemaître N; Titecat M; Merchez M; Deloison G; Ricard I; Pradel E; Marceau M; Sebbane F
    J Infect Dis; 2014 Nov; 210(9):1367-75. PubMed ID: 24813471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the Pla protease substrate α2-antiplasmin on the progression of primary pneumonic plague.
    Eddy JL; Schroeder JA; Zimbler DL; Bellows LE; Lathem WW
    Infect Immun; 2015 Dec; 83(12):4837-47. PubMed ID: 26438794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The characteristics of the action of the capsular antigen of Yersinia pestis on cells from plague-susceptible and -insusceptible rodents].
    Kagramanov VS; Aseeva LE; Varivoda TIu
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):13-6. PubMed ID: 10851982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Apoptosis of phagocytes as one of the probable mechanisms of the pathogenetic action of Yersinia pestis "mouse" toxin].
    Vasil'eva GI; Kiseleva AK; Mishan'kin MB; Kozlovskiĭ VN; Mishan'kin BN
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (2):49-52. PubMed ID: 15881939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Deadly Path: Bacterial Spread During Bubonic Plague.
    Gonzalez RJ; Miller VL
    Trends Microbiol; 2016 Apr; 24(4):239-241. PubMed ID: 26875618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiology: perspectives on plague.
    Dell H
    Nature; 2005 Dec; 438(7070):926. PubMed ID: 16355204
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanisms of high sensitivity of Mongolian pika spp. (Pallas) to Yersinia pestis].
    Kosilko SA; Innokent'eva TI
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (2):58-63. PubMed ID: 12043155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice naturally resistant to Yersinia pestis Delta pgm strains commonly used in pathogenicity studies.
    Congleton YH; Wulff CR; Kerschen EJ; Straley SC
    Infect Immun; 2006 Nov; 74(11):6501-4. PubMed ID: 16954401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Neutrophil Primary Granule Release during Yersinia pestis Pulmonary Infection.
    Eichelberger KR; Jones GS; Goldman WE
    mBio; 2019 Dec; 10(6):. PubMed ID: 31822588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive response of Yersinia pestis to extracellular effectors of innate immunity during bubonic plague.
    Sebbane F; Lemaître N; Sturdevant DE; Rebeil R; Virtaneva K; Porcella SF; Hinnebusch BJ
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11766-71. PubMed ID: 16864791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.